Call the shots: vaccine cuts imperil global h...

AI is changing how we work. It's turning us all into managers. Be a good one.The Economist’s management columnist, Andrew Palmer, takes on the bots in the third season of Boss Class. From cloning to coding, agents to entry-level jobs, he tackles the threat head on and figures out ...  Show more

After an astonishing week, Donald Trump has said America will not take Greenland by force, nor put tariffs on those who oppose his acquisition plan. Our correspondent asks if America-Europe relations can ever be repaired. A deal to transfer TikTok to American ownership is due tod ...  Show more

America’s health secretary, RFK Jr, is known for his opposition to vaccines, particularly mRNA jabs, that have the potential to treat a large swathe of diseases. Slashing funding will have long term implications beyond America. Our correspondent visits Britain’s biggest and newes ...  Show more

Mpox is spreading fast across Africa, yet public information campaigns are scant and vaccines in short supply. Is a new pandemic in the offing? Strategists are pondering a new potential threat from Russia: the possibility that it could detonate a <a href="https://www.economist ...

Trade ties between <a href="https://www.economist.com/the-americas/2024/11/17/brazil-courts-china-as-its-musk-feud-erupts-again?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term= ...

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more